Chemoinformaics analysis of 5,3-Dihexanoyl 3,6,7,4- tetramethoxyflavone
Molecular Weight | 390.344 | nRot | 5 |
Heavy Atom Molecular Weight | 372.2 | nRig | 18 |
Exact Molecular Weight | 390.095 | nRing | 3 |
Solubility: LogS | -3.777 | nHRing | 1 |
Solubility: LogP | 2.606 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 2 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 9 | No. of Arom Bond | 17 |
nHA | 9 | APOL | 50.9503 |
nHD | 3 | BPOL | 27.6057 |
QED | 0.602 |
Synth | 2.71 |
Natural Product Likeliness | 1.398 |
NR-PPAR-gamma | 0.932 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.998 |
Pgp-sub | 0.002 |
HIA | 0.053 |
CACO-2 | -5.007 |
MDCK | 0.0000187 |
BBB | 0.003 |
PPB | 0.86043 |
VDSS | 0.835 |
FU | 0.262182 |
CYP1A2-inh | 0.586 |
CYP1A2-sub | 0.978 |
CYP2c19-inh | 0.065 |
CYP2c19-sub | 0.131 |
CYP2c9-inh | 0.571 |
CYP2c9-sub | 0.75 |
CYP2d6-inh | 0.077 |
CYP2d6-sub | 0.325 |
CYP3a4-inh | 0.44 |
CYP3a4-sub | 0.273 |
CL | 3.544 |
T12 | 0.85 |
hERG | 0.18 |
Ames | 0.28 |
ROA | 0.249 |
SkinSen | 0.649 |
Carcinogencity | 0.018 |
EI | 0.872 |
Respiratory | 0.213 |
NR-Aromatase | 0.869 |
Antiviral | Yes |
Prediction | 0.907026 |